ArticleTrials2023
A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials.
Se Yoon LeePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleTrials2023
Se Yoon LeePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.